Results 151 to 160 of about 11,886 (196)

Complement C5 inhibition with eculizumab or ravulizumab is associated with increased cardiovascular and thromboembolic risk after ST-elevation myocardial infarction: a propensity-matched global retrospective cohort study. [PDF]

BMC Cardiovasc Disord
Vahldieck C.
europepmc   +1 more source

Case Report: Use of telitacicept for ocular myasthenia gravis. [PDF]

Front Immunol
Yang A, Zhao J, Li F, Pang R, Zang W.
europepmc   +1 more source

Complement Dysregulation in Kidney Diseases: Mechanisms, Biomarkers, and Emerging Targeted Therapies. [PDF]

Int J Mol Sci
Jesiołowski P, Krzywda M, Furmańczyk-Zawiska A, Durlik M.   +3 more
europepmc   +1 more source

Paroxysmal Nocturnal Haemoglobinuria-Associated Acute Cutaneous Thrombosis and Haemolysis in the Setting of Parvovirus B19 and Varicella Zoster Virus Infection. [PDF]

EJHaem
Potter LJ, Trikha R, Gandhi S, Large J, Basu TN, Boissiere J, Devine H, Sugai T, Rasool A, Kulasekararaj A.   +9 more
europepmc   +1 more source

Comparative Efficacy of Complement Inhibitors in Complement Inhibitor-Naïve PNH: A Systematic Review With Supportive Exploratory Network Meta-Analysis of Randomized Trials. [PDF]

EJHaem
Ishaque R, Talpur AS, Sidra H, Memon H, Memon FT, Talat F, Rafiq T, Rayamajhi S.   +7 more
europepmc   +1 more source

Direct Switch From Iptacopan to Pegcetacoplan in a Patient With Paroxysmal Nocturnal Hemoglobinuria. [PDF]

EJHaem
Latyshev V, Fidarova Z, Lukina E, Parovichnikova E.   +3 more
europepmc   +1 more source

Effectiveness and Safety of Eculizumab in Highly Active AChR+gMG and Its Therapeutic Response in Different Subtypes of gMG. [PDF]

Immunotargets Ther
Ma T, Liu Y, Zhu Y, Gao Y, Wang X, Liang Y, Wang B, Zhu R.   +7 more
europepmc   +1 more source

Use of narsoplimab for eculizumab-refractory adult transplant-associated thrombotic microangiopathy (TA-TMA). [PDF]

Ann Hematol
Young S, Varadarajan I.
europepmc   +1 more source

Real life use of ravulizumab in Italian patients with paroxysmal nocturnal hemoglobinuria: evidence from the REACTION observational study. [PDF]

Ann Hematol
Iori AP, De Vivo A, Di Bona E, Caocci G, Fioritoni F, Ciceri F, Beggiato E, Rapezzi D, Amendola A, Figuera A, Selleri C, Longu F, Fattizzo B, Tucci A, Cignetti A, Amico V, Sica S, Metafuni E, Raso S, Urbano TA, Marano L, Di Renzo N, Spedini P, Rambaldi A, Lanza F, Clissa C, Danesin C, Greve MB, Cabibbo S, Ori A, Cassanelli F, Sottana F, Campolo B, Gasparri G, Carini F, Barcellini W.   +35 more
europepmc   +1 more source

New Anticomplement Drugs in Nephrology: Mechanism and Indication.

Kidney Blood Press Res
Macciò L, Russo E, Costigliolo F, Battaglia Y, Viazzi F, Esposito P.   +5 more
europepmc   +1 more source